Bio-Rad
ProfileJobs (238)

Bio-Rad

Suggest Edit
    • Healthcarebiotechclinicsdiagnosticsdrug developmentlife sciences
    Bio-Rad develops, manufactures, and markets a broad range of products and solutions for the life science research and clinical diagnostics markets. The Company operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cell biology, and food safety. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls that serve clinical laboratories in the diagnostics market. Its products include reagents, instruments, and software which address specific niches within the in vitro diagnostics (IVD) test market.
    Revenue(FY, 2016)
    $2.1 B
    Market capitalization(2018-08-16)
    $9.5 B
    Type
    Public
    HQ
    Hercules, US
    Founded
    1952
    Size (employees)
    8,000 (est)-3%
    Website
    bio-rad.com
    Bio-Rad was founded in 1952 and is headquartered in Hercules, US
    Report incorrect company information

    Key People/Management at Bio-Rad

    Norman Schwartz

    Norman Schwartz

    Chairman of the Board, President and Chief Executive Officer
    Giovanni Magni

    Giovanni Magni

    EVP, Chief Strategy Officer
    John Goetz

    John Goetz

    EVP, Chief Operating Officer
    Michael Crowley

    Michael Crowley

    EVP, Global Commercial Operations
    John Hertia

    John Hertia

    EVP, President, Clinical Diagnostics Group
    Tim Ernst

    Tim Ernst

    EVP, General Counsel & Secretary
    Show more

    Bio-Rad Office Locations

    Bio-Rad has offices in Gladesville, Wien, Pudong, København and in 22 other locations
    Hercules, US (HQ)
    1000 Alfred Nobel Dr
    Hercules, US
    4000 Alfred Nobel Dr
    Gladesville, AU
    Level 5, 446 Victoria Road
    Wien, AT
    88 Hummelgasse
    Pudong, CN
    3rd Floor, Build E Poly Plaza, No.18 Dong Fang Road, Pudong
    København, DK
    Symbion Science Park Fruebjergvej 3
    Show all (27)
    Report incorrect company information

    Bio-Rad Financials and Metrics

    Bio-Rad Revenue

    Bio-Rad's revenue was reported to be $2.07 b in FY, 2016 which is a 2.4% increase from the previous period.
    USD

    Revenue (Q2, 2018)

    		1.1 b

    Gross profit (Q2, 2018)

    		603.9 m

    Gross profit margin (Q2, 2018), %

    		53.6%

    Market capitalization (16-Aug-2018)

    		9.5 b

    Closing stock price (16-Aug-2018)

    		317.9

    Cash (30-Jun-2018)

    		403 m
    Bio-Rad's current market capitalization is $9.5 b.
    Annual
    USDFY, 2013FY, 2014FY, 2015FY, 2016

    Revenue

    		2.1 b2.2 b2 b2.1 b

    Revenue growth, %

    		2%(7%)2%

    Cost of goods sold

    		897.8 m930.1 m

    Gross profit

    		1.1 b1.1 b
    Quarterly
    USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q1, 2018Q2, 2018

    Revenue

    		505.1 m509.3 m536.8 m530.6 m472.8 m506.1 m470 m471.2 m516.8 m508.7 m500.1 m504.7 m551.5 m1.1 b

    Cost of goods sold

    		220.9 m234.1 m239.6 m242.1 m202.7 m226.5 m206.5 m207.2 m236.5 m229.3 m230.1 m231.4 m249.3 m523.6 m

    Gross profit

    		284.2 m275.3 m297.2 m288.6 m270.1 m279.6 m263.5 m264 m280.2 m279.5 m270 m273.3 m302.2 m603.9 m

    Gross profit Margin, %

    		56%54%55%54%57%55%56%56%54%55%54%54%55%54%
    show all
    Annual
    USDFY, 2013FY, 2014FY, 2015FY, 2016

    Cash

    		331.6 m413.3 m457.5 m456.3 m

    Inventories

    		525 m

    Current Assets

    		1.7 b1.7 b1.8 b1.8 b
    Quarterly
    USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q1, 2018Q2, 2018

    Cash

    		291.8 m364.5 m384.7 m424.6 m425.7 m450.1 m507.3 m403.6 m418.7 m417.9 m291.7 m321.6 m407.3 m403 m

    Accounts Receivable

    		383.5 m383.9 m378.9 m354.4 m342.2 m354.2 m341.5 m381.1 m366.3 m367.7 m373.4 m392.8 m430.4 m404.1 m

    Inventories

    		523.5 m513.9 m520.6 m516 m478.4 m501 m512.7 m533.3 m541.5 m556.4 m559.8 m580.6 m612.2 m591.4 m

    Current Assets

    		1.7 b1.8 b1.8 b1.8 b1.7 b1.7 b1.8 b1.8 b1.8 b1.9 b1.7 b1.8 b2 b2 b
    show all
    Annual
    USDFY, 2013FY, 2014FY, 2015FY, 2016

    Net Income

    		77.8 m88.8 m113.1 m

    Cash From Operating Activities

    		175.5 m273.3 m186.2 m216.4 m
    Quarterly
    USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q1, 2018Q2, 2018

    Net Income

    		31.6 m11.5 m17.8 m28.4 m17.4 m12.3 m30.3 m48.7 m12.4 m

    Accounts Payable

    		125.5 m126.6 m

    Cash From Operating Activities

    		40.3 m118.2 m

    Cash From Investing Activities

    		(18.8 m)(102.7 m)
    show all
    USDY, 2018

    Revenue/Employee

    		140.9 k

    Financial Leverage

    		1.4 x
    Show all financial metrics
    Report incorrect company information

    Competitors

    Abbott
    Healthcare - Public
    Immucor
    Healthcare - Private
    bioMerieux
    Healthcare - Public
    Synthetic Genomics
    Healthcare - Private
    Thermo Fisher Scientific
    Healthcare - Public
    Compare competitors

    Bio-Rad Online and Social Media Presence

    Embed Graph
    Report incorrect company information

    Bio-Rad Company Life and Culture

    Report incorrect company information
    Download PDF